ArticleCureus2026

Pembrolizumab-Induced Checkpoint Inhibitor-Associated Diabetes Mellitus in Triple-Negative Breast Cancer: A Case Report.

Shawlin Jahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.